Serum-derived exomiR-188-3p is a promising novel biomarker for early-stage ovarian cancer

The exosomal microRNAs (exomiRNAs) are promising novel biomarkers for clinical detection and prognosis assessment of human cancers. The aim of this study was to identify potential exomiRNAs as biomarkers in ovarian cancer (OC).

Saved in:
Bibliographic Details
Main Authors: Wang Mingyu, Zhang Wenwen, Cheng Guangyan, Xu Juan, Qu Pengpeng
Format: Article
Language:English
Published: De Gruyter 2025-08-01
Series:Open Medicine
Subjects:
Online Access:https://doi.org/10.1515/med-2025-1266
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849225139563003904
author Wang Mingyu
Zhang Wenwen
Cheng Guangyan
Xu Juan
Qu Pengpeng
author_facet Wang Mingyu
Zhang Wenwen
Cheng Guangyan
Xu Juan
Qu Pengpeng
author_sort Wang Mingyu
collection DOAJ
description The exosomal microRNAs (exomiRNAs) are promising novel biomarkers for clinical detection and prognosis assessment of human cancers. The aim of this study was to identify potential exomiRNAs as biomarkers in ovarian cancer (OC).
format Article
id doaj-art-e0f51310fd674c24949bbc7536c5ece3
institution Kabale University
issn 2391-5463
language English
publishDate 2025-08-01
publisher De Gruyter
record_format Article
series Open Medicine
spelling doaj-art-e0f51310fd674c24949bbc7536c5ece32025-08-25T06:10:52ZengDe GruyterOpen Medicine2391-54632025-08-01201472710.1515/med-2025-1266Serum-derived exomiR-188-3p is a promising novel biomarker for early-stage ovarian cancerWang Mingyu0Zhang Wenwen1Cheng Guangyan2Xu Juan3Qu Pengpeng4Clinical College of Central Gynecology and Obstetrics, Tianjin Medical University, Tianjin, 300070, ChinaDepartment of Gynecological Oncology, Tianjin Central Hospital of Gynecology and Obstetrics, Tianjin, 300100, ChinaDepartment of Gynecological Oncology, Tianjin Central Hospital of Gynecology and Obstetrics, Tianjin, 300100, ChinaDepartment of Gynecological Oncology, Tianjin Central Hospital of Gynecology and Obstetrics, Tianjin, 300100, ChinaDepartment of Gynecological Oncology, Tianjin Central Hospital of Gynecology and Obstetrics, No. 156, Nankai Sanma Road, Xingnan Street, Nankai District, Tianjin, 300100, ChinaThe exosomal microRNAs (exomiRNAs) are promising novel biomarkers for clinical detection and prognosis assessment of human cancers. The aim of this study was to identify potential exomiRNAs as biomarkers in ovarian cancer (OC).https://doi.org/10.1515/med-2025-1266exosomal micrornasovarian cancerexomir-188-3pmetastasisbiomarker
spellingShingle Wang Mingyu
Zhang Wenwen
Cheng Guangyan
Xu Juan
Qu Pengpeng
Serum-derived exomiR-188-3p is a promising novel biomarker for early-stage ovarian cancer
Open Medicine
exosomal micrornas
ovarian cancer
exomir-188-3p
metastasis
biomarker
title Serum-derived exomiR-188-3p is a promising novel biomarker for early-stage ovarian cancer
title_full Serum-derived exomiR-188-3p is a promising novel biomarker for early-stage ovarian cancer
title_fullStr Serum-derived exomiR-188-3p is a promising novel biomarker for early-stage ovarian cancer
title_full_unstemmed Serum-derived exomiR-188-3p is a promising novel biomarker for early-stage ovarian cancer
title_short Serum-derived exomiR-188-3p is a promising novel biomarker for early-stage ovarian cancer
title_sort serum derived exomir 188 3p is a promising novel biomarker for early stage ovarian cancer
topic exosomal micrornas
ovarian cancer
exomir-188-3p
metastasis
biomarker
url https://doi.org/10.1515/med-2025-1266
work_keys_str_mv AT wangmingyu serumderivedexomir1883pisapromisingnovelbiomarkerforearlystageovariancancer
AT zhangwenwen serumderivedexomir1883pisapromisingnovelbiomarkerforearlystageovariancancer
AT chengguangyan serumderivedexomir1883pisapromisingnovelbiomarkerforearlystageovariancancer
AT xujuan serumderivedexomir1883pisapromisingnovelbiomarkerforearlystageovariancancer
AT qupengpeng serumderivedexomir1883pisapromisingnovelbiomarkerforearlystageovariancancer